Study to Evaluate if the Drug Vasopressin Protects the Kidneys for Patients Undergoing Liver Transplant

Completed · Not applicable · Has a placebo group

Conditions studied: Liver Failure

In brief

The purpose of this study is evaluate the medication vasopressin for its ability to preserve kidney function in patients undergoing liver transplantation.

Key facts

Study ID

NCT00886262

Run by

Medical University of South Carolina

People needed

18

Starts

2007-07-01

Expected to finish

2011-08-01

Last updated by the study team

2018-10-17

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• > 18 years of age
• undergoing liver transplant
• ability to provide informed consent. If patient is unable to give informed consent i.e. hepatic encephalopathy, consent may be obtained from the patient's legally authorized representative

You may not qualify if…

• < 18 years of age
• renal failure

Where it is running

• Medical University of South Carolina — Charleston, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.